Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eSense-Lab has developed a proprietary platform that analyzes and reverse-engineers the terpene profiles of plants. The company’s technology enables the creation of unique, sustainable terpene blends with potential medicinal applications. It has received approval from Israel's Ministry of Health to test its compounds against viruses including SARS-CoV strains. Early commercial traction includes joint ventures producing antiviral sanitizers using their proprietary terpenes. Broader R&D plans target evidence-based medical uses across several therapeutic areas including virology, oncology, neurodegeneration, fibrosis, COPD, and endometriosis
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eSense-Lab.